One in Two

In this episode, we speak to Dr Fabio Gomes, a Consultant Medical Oncologist at The Christie NHS Foundation Trust, about lung cancer in never smokers, focusing on: The commonality of lung cancer in never smokers Why never smokers are susceptible to lung cancer, and why you only need lungs to get lung cancer ALK positive mutations in non-small cell lung cancer His research project looking at The UK ALK project The ALK Education programme and educating healthcare professionals through data and case studies Speaker profile:    Dr Fabio Gomes is a Consultant Medical Oncologist who specialises in the care of patients with lung cancer, focussing specifically on the ALK positive mutation in Non-small cell lung cancer (NSCLC). He also has a special interest in the care of senior adults with cancer and is the Clinical Director of the multidisciplinary senior adult oncology service launched at The Christie in 2022. Fabio also works with the digital services where he directs the clinical outcomes unit. This unit focuses on the use of clinical data generated as part of the daily practice across the hospital to identify the outcomes of groups of patients and promote improvements. Dr Gomes is an elected board member of the International Society of Geriatric Oncology (SIOG). He is also a Clinical Research Training Fellow alum at The University of Manchester. Show notes:  Dr Fabio Gomes’ research profile Non-small cell lung cancer information from Macmillan The ALK project: A real-work national network and database ALK Positive UK ALK Positive Org Ruth Strauss Foundation

Show Notes

 In this episode, we speak to Dr Fabio Gomes, a Consultant Medical Oncologist at The Christie NHS Foundation Trust, about lung cancer in never smokers, focusing on:
  •  The commonality of lung cancer in never smokers
  •  Why never smokers are susceptible to lung cancer, and why you only need lungs to get lung cancer
  •  ALK positive mutations in non-small cell lung cancer
  •  His research project looking at The UK ALK project
  •  The ALK Education programme and educating healthcare professionals through data and case studies
 Speaker profile:   
 Dr Fabio Gomes is a Consultant Medical Oncologist who specialises in the care of patients with lung cancer, focussing specifically on the ALK positive mutation in Non-small cell lung cancer (NSCLC). He also has a special interest in the care of senior adults with cancer and is the Clinical Director of the multidisciplinary senior adult oncology service launched at The Christie in 2022.
 Fabio also works with the digital services where he directs the clinical outcomes unit. This unit focuses on the use of clinical data generated as part of the daily practice across the hospital to identify the outcomes of groups of patients and promote improvements.
 Dr Gomes is an elected board member of the International Society of Geriatric Oncology (SIOG). He is also a Clinical Research Training Fellow alum at The University of Manchester.
Show notes: 
 Dr Fabio Gomes’ research profile
 Non-small cell lung cancer information from Macmillan
 The ALK project: A real-work national network and database
 ALK Positive UK
 ALK Positive Org
 Ruth Strauss Foundation

What is One in Two?

With one in two of us receiving a cancer diagnosis at some point during our lives, it has never been more important to improve the outcomes for people affected by cancer.

This cancer research podcast is brought to you by The University of Manchester in partnership with the Manchester Cancer Research Centre (MCRC). In each episode, our cancer researchers discuss the innovations, discoveries and projects that are changing the landscape of early detection.